June 18, 2025

For many veterans, the wounds of war linger long after their service ends. In a powerful op-ed for Homeland Magazine, Dr. Lucas Trautman, Medical Director of Oxford Treatment Center’s veteran program, explores emerging hope on the front lines of PTSD treatment: psychedelic-assisted therapy. He highlights promising compounds like ketamine, ibogaine, and ayahuasca—not as quick fixes, but as life-saving interventions when used with care and medical oversight.

Dr. Trautman shares the compelling story of a Marine Corps veteran who sought ibogaine treatment abroad and found a profound breakthrough after years of struggling. His message is clear: it’s time to invest in safe, science-backed infrastructure to offer these therapies to the veterans who need them most. Read the full article.